Why Are Three Injections Required for Lipolysis Injections?

Apr 28, 2022 Source: Cainiu Health
Dr. Li Qiang
Introduction
Three injections of lipolytic agents are administered to establish a relatively stable fat-reduction effect. The first injection initiates the fat-decomposition process, producing only preliminary results. The second injection further accelerates and deepens fat reduction based on the initial effect. The third injection consolidates these results, ensuring complete disintegration and metabolic elimination of adipocytes. Only through this sequential, sustained three-injection regimen can the fat-reduction effect become both pronounced and long-lasting.

Typically, the reason for administering three injections of fat-dissolving injections varies among individuals but is generally related to establishing stable results, aligning with the body’s metabolic rhythm, and enabling precise dose control. Below is a detailed analysis:

Three injections are administered to achieve relatively stable lipolysis (fat dissolution). The first injection initiates the fat breakdown process, producing only preliminary effects; the second injection further accelerates and deepens lipolysis based on the initial response; and the third injection consolidates the results, ensuring thorough disintegration and metabolic clearance of adipocytes. Only through this sustained, three-stage intervention can the lipolytic effect become both long-lasting and visibly apparent.

The human body metabolizes substances according to a specific cycle and rate. Administering three injections aligns with this natural metabolic rhythm: following the first injection, the body begins processing the disrupted fat cells; the second injection continues to drive lipolysis in synchrony with ongoing metabolism; and the third injection reinforces the effect and supports efficient elimination of the dissolved fat. This three-injection schedule harmonizes with the body’s metabolic pathway, ensuring orderly excretion of the dissolved fat and minimizing residual accumulation.

Due to safety considerations, the dosage per single injection of fat-dissolving agents is intentionally limited to avoid adverse reactions. Dividing the total therapeutic dose across three separate injections allows for precise overall dose management and staged delivery. The first injection uses a small “test” dose to assess the individual’s physiological response; subsequent doses are then adjusted accordingly to ensure optimal and safe dose distribution.

After receiving fat-dissolving injections, some patients may experience transient side effects such as redness or localized pain—these are typically normal and usually resolve spontaneously within several days. However, if symptoms persist beyond this timeframe or are accompanied by other unusual manifestations, prompt medical evaluation and follow-up are recommended.